Table 1 Patients excluded from MRgFUS treatment following MRI screening
Reason for Exclusion | Percentage of Patients (%) | Number of Patients |
|---|---|---|
Fibroid number (>6) | 33 | 45 |
Possible malignancy | 14 | 19 |
Diffuse adenomyosis | 12 | 16 |
Non-enhancing fibroids (calcified, hemmorrhagic, necrotic) | 11 | 15 |
Fibroid size > 10 cm | 9 | 12 |
Fibroid size < 2 cm | 6 | 8 |
Pedunculated fibroid | 4 | 5 |
Hyperintense T2-weighted signal | 5 | 7 |
Metal in beampath | 3 | 4 |
Fibroid location > 12cm from skin | 1 | 2 |
Obesity {subcutaneous fat layer > 4.0 cm) | 1 | 1 |
Prior Liposuction | 1 | 1 |